• Something wrong with this record ?

Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial

PFA. Mulders, L. Martínez-Piñeiro, A. Heidenreich, M. Babjuk, M. Colombel, R. Colombo, P. Radziszewski, I. Korneyev, C. Surcel, P. Yakovlev, JA. Witjes, C. Caris, R. Schipper, WPJ. Witjes, MAGNOLIA Study Group of the EAU Research Foundation,

. 2019 ; 5 (5) : 849-852. [pub] 20180221

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

The MAGNOLIA study, investigating the concept of perioperative immunotherapy in muscle- invasive bladder cancer, was prematurely terminated. The lessons learned that should be considered before initiating and conducting future clinical trials in this field are highlighted.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028829
003      
CZ-PrNML
005      
20210114155213.0
007      
ta
008      
210105s2019 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.euf.2018.02.005 $2 doi
035    __
$a (PubMed)29477797
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Mulders, Peter F A $u Radboud University Medical Centre, Nijmegen, The Netherlands.
245    10
$a Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial / $c PFA. Mulders, L. Martínez-Piñeiro, A. Heidenreich, M. Babjuk, M. Colombel, R. Colombo, P. Radziszewski, I. Korneyev, C. Surcel, P. Yakovlev, JA. Witjes, C. Caris, R. Schipper, WPJ. Witjes, MAGNOLIA Study Group of the EAU Research Foundation,
520    9_
$a The MAGNOLIA study, investigating the concept of perioperative immunotherapy in muscle- invasive bladder cancer, was prematurely terminated. The lessons learned that should be considered before initiating and conducting future clinical trials in this field are highlighted.
650    _2
$a antigeny nádorové $x terapeutické užití $7 D000951
650    _2
$a adjuvantní chemoterapie $7 D017024
650    _2
$a klinické zkoušky, fáze II jako téma $7 D017322
650    _2
$a cystektomie $7 D015653
650    _2
$a dvojitá slepá metoda $7 D004311
650    _2
$a předčasné ukončení klinických zkoušek $7 D057239
650    _2
$a lidé $7 D006801
650    12
$a imunoterapie $7 D007167
650    _2
$a invazivní růst nádoru $7 D009361
650    _2
$a nádorové proteiny $x terapeutické užití $7 D009363
650    _2
$a randomizované kontrolované studie jako téma $7 D016032
650    _2
$a rekombinantní proteiny $x terapeutické užití $7 D011994
650    _2
$a nádory močového měchýře $x farmakoterapie $x patologie $x chirurgie $7 D001749
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Martínez-Piñeiro, Luis $u Hospital La Paz, Madrid, Spain.
700    1_
$a Heidenreich, Axel $u Universitätsklinikum Köln, Köln, Germany.
700    1_
$a Babjuk, Marko $u Hospital Motol, Charles University, Prague, Czech Republic.
700    1_
$a Colombel, Marc $u Hôpital Edouard Herriot, Lyon, France.
700    1_
$a Colombo, Renzo $u University Vita Salute San Raffaele Hospital, Milan, Italy.
700    1_
$a Radziszewski, Piotr $u Medical University Warsaw, Warsaw, Poland.
700    1_
$a Korneyev, Igor $u Saint Petersburg State Pavlov Medical University, St. Petersburg, Russia.
700    1_
$a Surcel, Cristian $u University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
700    1_
$a Yakovlev, Pavel $u Kiev Municipal Oncology Hospital, Kiev, Ukraine.
700    1_
$a Witjes, J Alfred $u Radboud University Medical Centre, Nijmegen, The Netherlands.
700    1_
$a Caris, Christien $u EAU Research Foundation, Arnhem, The Netherlands.
700    1_
$a Schipper, Raymond $u EAU Research Foundation, Arnhem, The Netherlands.
700    1_
$a Witjes, Wim P J $u EAU Research Foundation, Arnhem, The Netherlands. Electronic address: w.witjes@curatrial.com.
710    2_
$a MAGNOLIA Study Group of the EAU Research Foundation
773    0_
$w MED00193513 $t European urology focus $x 2405-4569 $g Roč. 5, č. 5 (2019), s. 849-852
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29477797 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114155212 $b ABA008
999    __
$a ok $b bmc $g 1609164 $s 1120009
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 5 $c 5 $d 849-852 $e 20180221 $i 2405-4569 $m European urology focus $n Eur Urol Focus $x MED00193513
LZP    __
$a Pubmed-20210105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...